Background: Psoriasis is a chronic and prevalent disease, and the associated pruritus is a common, difficult-tocontrol symptom. The mediators involved in psoriatic pruritus have not been fully established. oBjective: To evaluate associations between the number of mast cells in psoriatic lesions and the intensity of pruritus. Methods: 29 patients with plaque psoriasis were recruited. In all participants, Psoriasis Area and Severity Index and Body Surface Area were assessed. A questionnaire was administered to obtain clinical information and the Dermatology Life Quality Index. Pruritus was assessed using a visual analog scale and skin biopsies were performed for staining with Giemsa and Immunohistochemistry with C-Kit. results: Pruritus was observed in 91.3% of our patients. Median VAS was 6 (p25-75: 2-8). The immunohistochemical method revealed a mean of 11.32 mast cells/field and Giemsa staining revealed a mean of 6.72 mast cells/field. There was no correlation between the intensity of pruritus and mast cell count, neither in Immunohistochemistry (p = 0.15; rho = -0.27) nor in Giemsa (p = 0.16; rho = -0.27). Pruritus did not impact on the Dermatology Life Quality Index (p = 0.51; rho = -0.13). study liMitations: The small sample size may be considered the main limitation of our study. conclusions: Although mast cells are mediators of pruritus in many cutaneous diseases, our findings support that psoriatic pruritus is a complex disorder with multifactorial, complex pathophysiology, involving pruritogenic mediators others than mast cells.
INTRODUCTION
Psoriasis is a chronic, inflammatory and immune-mediated condition, with a prevalence of 1-3% in Western countries. 1, 2 Pruritus is seen in 70% to 90% of patients with psoriasis. [3] [4] [5] [6] Despite being a very frequent symptom, pathophysiology of pruritus in psoriasis it
is not yet understood. 7 Many studies demonstrate increased expression of substance P in psoriasis plaques, being this substance also implicated in the inflammatory and proliferative process of other skin conditions. 8 The presence of mast cells in established plaques and in early lesions of psoriasis has been documented in many studies, with the increase in number and the early activation of cutaneous mast cells typical findings of psoriatic inflammation. [9] [10] [11] [12] [13] One of the early morphological changes observed is mast cell degranulation. 14, 15 In active lesions and in nonaffected skin of patients with psoriasis, mast cell degranulation is associated to vascular changes and angiogenesis. 14, 16 Both phenomena are vitally important in the pathophysiology of psoriasis.
The majority of patients incriminates stress as a triggering factor for both psoriasis lesions and the pruritus associated to the condition. 3, 18 The mechanism by which stress triggers pruritus in psoriasis is not clear, however, it is known that emotional stress changes the levels of certain neuropeptides like substance P, either in the CNS or in the tissues. 20 Substance P, besides being one of the most potent endogenous pruritogenic peptides, when increased in situations of stress, can lead to mast cell degranulation. 20, 21 There are few studies regarding the quantification of mast cells in psoriasis lesions. This is one of the few studies that proposes to evaluate the relationship between the amount of mast cells in psoriasis lesions with the intensity of the pruritus.
METHODS
It is a cross-sectional study design, conducted from April to December 2013. During this period, patients 18 years of age or older, with psoriasis vulgaris who were patients at the ambulatory of psoriasis of the service of dermatology at Hospital de Clínicas de Porto Alegre were invited to participate in the study. The sampling was performed by convenience, with 29 patients included in the study after the eligibility criteria. Were considered exclusion criteria: patients taking medications that induce mast cell degranulation, pregnancy and patients being treated with phototherapy. Altman technique and evaluated by the intraclass correlation coefficient (ICC) for perfect concordance (random two-way). 22 A level of significance of 5% was considered.
RESULTS

Clinical and epidemiological characteristics
Of the 29 patients participating in the study, 44.8% were male and 55.2% female, with a mean age of 50 years. Of those, 89.7%
were Caucasian. Median time of the disease was of 18 years (I r 11-30.5) and family history of psoriasis was present in 37.9% of those studied.
Most patients (65.5%) had been using some type of medication for the treatment of psoriasis: 20.7% were using methotrexate (MTX), 6.9% acitretin, 58.6% topical steroids and 17.2% formulations with liquor carbonis detergens (LCD) and salicylic acid (SA). 72.4% of cases, the most frequent were stress/anxiety (27.6%) and exposure to heat (27.6%). Showering was described as an alleviating factor for the pruritus of eight patients (27.6%) and as a triggering factor by three (10.3%). In table 2 , we compared the density of mast cells (mean variable for both stains -IHC and GIEMSA) in patients who were using some treatment for psoriasis (topical or systemic) and those who were not using any treatment at the time of the study, with no statistically significant difference between those. Even though patients using mast cell degranulating drugs were excluded from the study, the use of drugs for the treatment of psoriasis could have altered the mast cell count in the lesions of psoriasis, as well as the assessment of pruritus of these patients. 
Evaluation of skin biopsies
DISCUSSION
Psoriasis is a chronic, stigmatizing dermatological disease of difficult management, many times with systemic involvement and negative impact on the quality of life of the patients. Pruritus is a frequent symptom; however, it is many times underestimated in patients with psoriasis, contributing even further to reduce quality of life of those affected. 23 Bilac et al 24 assessed 87 patients with psoriasis and found a higher frequency of pruritus in patients with DLQI≥10. Different to these findings, we did not find an association between pruritus and quality of life in the population of our study. 19 we did not find a relationship between pruritus and psoriasis severity, even though this association was reported by other authors. 5 With similar results, Prignano et al. 18 did not identify a statistically significant correlation between the presence and intensity of pruritus with the patient's age, sex, and psoriasis severity according to PASI scores either.
For the adequate management of pruritus in psoriasis, it is necessary to understand its pathophysiology. Nakamura et al. 19 were the first to document the local market is associated to pruritus in psoriasis through histological examination of the lesions of 38 symptomatic patients compared to the findings in asymptomatic patients. The peculiar feature of finding mast cells in lesions of patients with pruritus was the presence of granules closely juxtaposed to the perineurium of non-myelinated nerve fibers, finding that was not seen in any patient without pruritus. Contrary to our findings, the authors observed the large amount of degranulating mast cells in the papillary dermis of patients with pruritus. However, in the above-mentioned study, the patients discontinued their psoriasis topical treatments two weeks before starting the study, and the systemic treatments three months before. In our study, both topical and systemic treatment for psoriasis were maintained, representing a possible limitation, because it is known that the use of topical steroids and some systemic medications such as retinoids in cyclosporine can reduce the mast cell count. 26 The major limitation of our study was the small sample size,
with an estimated calculation in order to detect a moderate correlation with a value of r≥ 0.5, considering a strength of 80% and the significance level of 0.05. However, it is also important to note that we did not consider the time of the lesions or the biopsy site (if in a photoexposed area or not) in our results. These data could alter our results, since a higher density of mast cells can be seen in recent lesions of psoriasis and in photoexposed areas since mast cells are activated and recruited by ultraviolet and infrared radiation, as well as by heat. Fabiana Bazanella Oliveira 0000-0002-5278-3153
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